PLX

Protalix Biotherapeutics Inc

Price

$2.55

return (12m)

64.19%

p/e

10.17

p/bv

2.70

DIVIDEND YIELD

0.00%

PLX price

Protalix Biotherapeutics Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PLX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.38%

3 months

20.62%

1 year

64.19%

2 years

179.64%

5 years

62.10%

10 years

-57.44%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PLX

Valuation

P/E

10.17

Sector 7.65

Industry 7.65

P/BV

2.70

Sector 1.91

Industry 1.91

P/Revenue (PSR)

2.39

Sector 1.92

Industry 1.92

EV/EBITDA

Sector -630.62

Industry -630.62

EV/EBIT

Sector -7,206,132,315.43

Industry -7,206,132,315.43

P/EBITDA

Sector -92.86

Industry -92.86

P/EBIT

Sector -91.56

Industry -91.56

P/Total Assets

1.75

Sector 0.90

Industry 0.90

P/Net Current Assets

3.62

Sector -2.52

Industry -2.52

P/Working Capital

3.17

Sector -4,940.99

Industry -4,940.99

EPS

0.24

Sector 0.72

Industry 0.72

BVPS

0.89

Sector 9.67

Industry 9.67

Efficiency

Gross Margin

69.19%

Sector 34.42%

Industry 34.42%

EBITDA Margin

0.00%

Sector 2.06%

Industry 2.06%

EBIT Margin

0.00%

Sector 0.23%

Industry 0.23%

Operating Margin

28.89%

Sector 4.20%

Industry 4.20%

Net Profit Margins

23.52%

Sector 2.40%

Industry 2.40%

Asset Turnover

0.18

Sector 0.11

Industry 0.11

Profitability

ROE

26.55%

Sector 1.42%

Industry 1.42%

ROA

17.18%

Sector -0.76%

Industry -0.76%

ROIC

0.00%

Sector -65.52%

Industry -65.52%

Dividends

Dividend yield

0.00%

Sector 0.49%

Industry 0.49%

Payout

0.00%

Sector 10.08%

Industry 10.08%

Debt

Current Ratio

2.94

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -109,118,343.39

Industry -109,118,343.39

Net Debt / EBIT

Sector -82.02

Industry -82.02

Net Debt / Equity

0.00

Sector -0.79

Industry -0.79

Gross Debt / Equity

0.00

Sector -0.39

Industry -0.39

Equity/Assets

0.65

Sector 0.42

Industry 0.42

Liabilities/Assets

0.35

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

16.02%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Protalix Biotherapeutics Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$2.55

Fair Value

$2.19

Upside Return potential.

-13.86%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PLX

DRAG THE FRAME TO SEE MORE DATA

PLX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Protalix Biotherapeutics Inc

Protalix Biotherapeutics Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Protalix Biotherapeutics Inc (United States) is listed on the Nasdaq and has a market capitalization of $192.80 million, with shareholders equity totaling $71.40 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Protalix Biotherapeutics Inc reported $80.62 million in revenue, generating net income of $18.96 million.

Key financial metrics include a P/E ratio of 10.17, a price-to-book (P/B) ratio of 2.70, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PLX.

Market cap

$192.80 million

Net worth

$71.40 million

$71,400,000.00

Assets

$110.34 million

$110,340,000.00

Total Shares Outstanding

80.00 million

80,000,000

Average Daily Trading Volume

$688.02 Thousand

$688,020.84

Sector

Others

Industry

Others

PLX

PLX revenue and profits

Financial Results PLX

DRAG THE FRAME TO SEE MORE DATA

PLX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$394.67 31,55% (12M)

P/E

23.98

2.26%

ROE

14.27%

P/BV

3.42

SHEL - Shell PLC ADR

$90.87 28,85% (12M)

P/E

9.92

3.21%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.40 --43,93% (12M)

P/E

-0.59

0.00%

ROE

-35.93%

P/BV

0.21

COR - Cencora Inc.

$322.26 11,56% (12M)

P/E

23.63

0.73%

ROE

81.48%

P/BV

19.25

SSNLF - Samsung Electronics Co Ltd

$65.21 62,28% (12M)

P/E

0.00

0.00%

ROE

7,749.65%

P/BV

0.00

ALIZY - Allianz SE ADR

$51.73 --7,97% (12M)

P/E

14.28

2.63%

ROE

17.89%

P/BV

2.55

TTE - TotalEnergies SE ADR

$86.62 49,34% (12M)

P/E

7.18

4.53%

ROE

21.42%

P/BV

1.54

NSRGY - Nestle SA ADR

$97.10 7,42% (12M)

P/E

12.00

4.01%

ROE

58.05%

P/BV

6.97